NSTEMI part 2. Pharmacotherapy: antiplatelets, anticoagulants, other therapies
HTML-код
- Опубликовано: 12 апр 2024
- 01:10 1-Other therapies
01:10 β-blocker: acute, long term, low EF, normal EF
10:14 ACE-I
13:21 Aldosterone antagonist
16:01 Entresto and SGLT-2 inhibitors
20:08 Summary slide
23:22 2-Antiplatelet therapy
23:22 Clopidogrel vs prasugrel vs ticagrelor: differences? which one to use? Factors to consider? Should we preload?
36:58 De-escalation from potent P2Y12 inhibitors DAPT to clopidogrel DAPT at 1 month
38:18 De-escalate to clopidogrel monotherapy at 1 month? Trials and guidelines
43:22 What is high ischemic risk? What is high bleeding risk?
46:50 De-escalate to ticagrelor monotherapy at 1 month? Trials
49:07 Patients who also require chronic anticoagulation
51:02 3-Anticoagulant therapy
52:07 UFH preferred to enoxaparin. Trials, guidelines
53:21 how to dose enoxaparin during cath and PCI- Disadvantages
57:54 Dose of UFH in ACS less than PE. Role of fondaparinux (59:35)
01:52:02 How to manage anticoagulation in ACS pre-cath and during cath in patients who are chronically taking warfarin or NOAC. Radial vs femoral
01:08:38 4-IV Glycoprotein IIb/III inhibitors (GPI) and IV Cangrelor
01:10:48 Cangrelor: when to use? It is not a bailout drug and has narrower indications than GPI
01:13:40 How to switch from cangrelor to oral P2Y12 antagonist
I’m an interventional/structural cardiology fellow in the US, set to graduate in 2 months. We have never met, but you’ve nevertheless been one of my greatest teachers over the years. How I would’ve loved to have trained under you Dr Hanna. Keep up your excellent work.
That is one of the nicest comments I have read, thank you!! I am very happy to hear that, and hopefully we meet one day.
Thank you Dr Hanna for your state of the art lectures, It always makes my day when I get a notification that you posted a new one, you're the best teacher I've ever had and I wish to meet to you one day when I come to the US to thank you face to face.
Same in my case!!
Such a kind comment, thank you! I am happy the videos had a positive impact on you. Yes, hopefully we meet one day
Thank you Doctor Hanna, very informative and in depth as always.
Greatest lecture, Doc. Elias Hanna. Your talent in explanation is at the unreal level, thank you!
Thank you for your kind words!
Your lectures should really be part of curriculum for fellowship program. Thanks for sharing your knowledge
Excellent lecture.....no words can explain my gratitude....
Please elaborate on for how long should we give beta blockers in patient post STEMI with persistently low EF.
Thank you! In that case, beta blocker should be kept long term, for as long as tolerated. In fact, even if EF recovers at 1 month, beta blocker should be continued long term based on the available data, especially if the initial EF is
Thanks alot dear dr. I am very excited to see and watch your very nice talk on cardiology and we get alot of benefit and update, we hope your more success in your life.
Dr.Hanna thanks alot for very useful lecture, please tell us about PTMC,ASD closure, TAVI...
Why is bridging with ufh needed during oral anticoagulation interruption? Thank u for your fantastic lecture dr. Hanna
Hey Dr. Hanna, I’m an IC Fellow in Texas. Your lectures have been a large portion of my knowledge foundation over the last couple years! Question about CMS requirements (usually outdated)… do you typically just explain why you don’t recommend B-Blocker therapy for a particular patient based on this newer data?
That is great to hear, thank you! Yes, you could provide an explanation. But keep in mind, as I explained at 09:29, that even if EF normal and the patient is lower risk, I still favor beta-blocker therapy for 30 days after acute MI (starting the 2nd day), as per COMMIT CCS trial and multiple registry data.
@@eliashanna8248wow what a lecture simple and Cristal clear and Do you have a book you will recommend me to read Dr.?